|
LABT Lakewood-amedex Biotherapeutics Inc 2079272 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-3,772,008.00 |
| Balance Sheet |
|
Current Assets
|
$4,845,299.00 |
|
Assets
|
$4,960,009.00 |
|
Current Liabilities
|
$628,926.00 |
|
Liabilities
|
$628,926.00 |
|
Equity
|
$4,331,083.00 |
|
Shares Out
|
2169199.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-2,453,721.00 |
|
Investing Cash Flow
|
$-2,000,000.00 |
| Market Analysis |
Market Cap
|
$4,750,545.81 |
|
Price
|
$2.19 |
|
BVPS
|
2.00 |
|
PB
|
1.10 |
|
EPS
|
-2.75 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:33:01 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:51 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view LABT documents filed with the SEC.
LABT Filings
Clear
